Retatrutide (development code LY3437943 ) is a 39-amino-acid synthetic peptide engineered as a triple agonist at three of the four principal incretin and glucagon-related receptors: GLP-1, GIP, and glucagon
Islam T, Manna M, Reddy MK
j , Cumulative food intake
This article covers how each drug affects GI motility, which drug classes do carry labeled interaction risks, and what to look for in a probiotic if you're on GLP-1 therapy
To further validate the role of the endogenous carnitine shuttle to the observed histone acetylation, we knocked down carnitine O -acetyltransferase (CrAT) and carnitine O -octanoyltransferase (CrOT) (Extended Data Fig
REIMAGINE 3 explored CagriSema as an add-on to basal insulin for individuals living with type 2 diabetes with or without metformin